Average Co-Inventor Count = 3.98
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Allergan, Inc. (37 from 2,285 patents)
37 patents:
1. 9371296 - Bicyclic 1,3,4-oxadiazole derivatives as sphingosine-1-phosphate receptors' modulators
2. 9120784 - 1,3,4-oxadiazoles-2-thio azetidine derivatives as sphingosine-1 phosphate receptors modulators
3. 9108993 - Pyrazole derivatives as sphingosine 1-phosphate (S1P) receptor modulators
4. 9062030 - Pyrazole azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulators
5. 9000016 - 1,3,4-Oxadiazoles-2-thio derivatives as sphingosine-1 phosphate receptors modulators
6. 8987471 - Substituted dihydropyrazoles as sphingosine receptor modulators
7. 8987467 - Substituted pyrazole azetidines as sphingosine receptor modulators
8. 8957051 - Bicyclic 1, 2, 4-oxadiazoles derivatives as sphingosine-1 phosphate receptors modulators
9. 8946195 - Bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
10. 8859598 - 1, 2, 4-oxadiazoles azetidine derivatives as sphingosine-1 phosphate receptors modulators
11. 8846729 - 2-thio-1,3,4-oxadiazoles azetidine derivatives as sphingosine-1 phosphate receptors modulators
12. 8809379 - Selective subtype alpha 2 adrenergic agents and methods for use thereof
13. 8735399 - Selective subtype alpha 2 adrenergic agents and methods for use thereof
14. 8729110 - 2-thio-1,3,4-oxadiazoles derivatives as sphingosine-1 phosphate receptors modulators
15. 8729109 - 3-(4-(5-phenyl-1 ,2,4-oxadiazol-3-yl)phenoxy)propan-2-ol derivatives as sphingosine-1phosphate receptors modulators